US20230158497A1 - Air to liquid micro-fluidic chamber - Google Patents
Air to liquid micro-fluidic chamber Download PDFInfo
- Publication number
- US20230158497A1 US20230158497A1 US18/151,935 US202318151935A US2023158497A1 US 20230158497 A1 US20230158497 A1 US 20230158497A1 US 202318151935 A US202318151935 A US 202318151935A US 2023158497 A1 US2023158497 A1 US 2023158497A1
- Authority
- US
- United States
- Prior art keywords
- fluorescence
- enzyme
- tbp
- organo
- acetylcholine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 40
- 239000007791 liquid phase Substances 0.000 claims abstract description 29
- 239000000758 substrate Substances 0.000 claims abstract description 18
- 238000000605 extraction Methods 0.000 claims abstract description 6
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 claims description 37
- 229960004373 acetylcholine Drugs 0.000 claims description 37
- 102000004190 Enzymes Human genes 0.000 claims description 36
- 108090000790 Enzymes Proteins 0.000 claims description 36
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 24
- 238000001514 detection method Methods 0.000 claims description 21
- 229910019142 PO4 Inorganic materials 0.000 claims description 20
- 108090000371 Esterases Proteins 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 17
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 13
- 229960001231 choline Drugs 0.000 claims description 13
- 230000001590 oxidative effect Effects 0.000 claims description 10
- 239000010452 phosphate Substances 0.000 claims description 10
- 239000000741 silica gel Substances 0.000 claims description 10
- 229910002027 silica gel Inorganic materials 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 9
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 9
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 9
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 claims description 7
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 claims description 7
- 230000007423 decrease Effects 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 102000003992 Peroxidases Human genes 0.000 claims description 4
- SXKNCCSPZDCRFD-UHFFFAOYSA-N betaine aldehyde Chemical compound C[N+](C)(C)CC=O SXKNCCSPZDCRFD-UHFFFAOYSA-N 0.000 claims description 4
- -1 cyclooxytenase Proteins 0.000 claims description 4
- 230000003100 immobilizing effect Effects 0.000 claims description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
- 239000012491 analyte Substances 0.000 abstract description 27
- 150000002894 organic compounds Chemical class 0.000 abstract description 27
- 238000012546 transfer Methods 0.000 abstract description 20
- 239000000356 contaminant Substances 0.000 abstract description 15
- 239000000872 buffer Substances 0.000 abstract description 12
- 230000007246 mechanism Effects 0.000 abstract description 8
- 238000010223 real-time analysis Methods 0.000 abstract description 5
- 230000008859 change Effects 0.000 abstract description 4
- 238000005842 biochemical reaction Methods 0.000 abstract description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 87
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 60
- 238000010586 diagram Methods 0.000 description 33
- 239000003570 air Substances 0.000 description 30
- 229940088598 enzyme Drugs 0.000 description 30
- 239000000523 sample Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 22
- 239000000243 solution Substances 0.000 description 20
- 239000012071 phase Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 102100033639 Acetylcholinesterase Human genes 0.000 description 14
- 108010022752 Acetylcholinesterase Proteins 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- 239000002904 solvent Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 239000000463 material Substances 0.000 description 11
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 9
- 238000001311 chemical methods and process Methods 0.000 description 8
- 230000005284 excitation Effects 0.000 description 7
- 239000011325 microbead Substances 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- 238000009792 diffusion process Methods 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000007306 functionalization reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004971 Cross linker Substances 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000012454 non-polar solvent Substances 0.000 description 4
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229930003827 cannabinoid Natural products 0.000 description 3
- 239000003557 cannabinoid Substances 0.000 description 3
- 229940065144 cannabinoids Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229940005483 opioid analgesics Drugs 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229940022698 acetylcholinesterase Drugs 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 230000006957 competitive inhibition Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000002174 soft lithography Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 1
- 108010000659 Choline oxidase Proteins 0.000 description 1
- 241000725101 Clea Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 108091008104 nucleic acid aptamers Proteins 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000011295 pitch Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- BOSMZFBHAYFUBJ-UHFFFAOYSA-N tris(4-methylphenyl) phosphate Chemical class C1=CC(C)=CC=C1OP(=O)(OC=1C=CC(C)=CC=1)OC1=CC=C(C)C=C1 BOSMZFBHAYFUBJ-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502738—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by integrated valves
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
- F16K99/00—Subject matter not provided for in other groups of this subclass
- F16K99/0001—Microvalves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
- F16K99/00—Subject matter not provided for in other groups of this subclass
- F16K2099/0082—Microvalves adapted for a particular use
- F16K2099/0084—Chemistry or biology, e.g. "lab-on-a-chip" technology
Definitions
- the embodiments herein generally relate to contaminant detectors, and more particularly to detectors of organo-phosphate compounds, opioids, cannabinoids, and other classes of organic compounds.
- an embodiment herein provides a system comprising a pump to deliver vapor comprising airborne contaminants comprising organic compounds comprising a target analyte; a collector to transfer the airborne contaminants by autonomous liquid extraction into a mobile organic liquid phase; a micro-fluidic chamber comprising immobilized biorecognition elements that bind to analytes delivered from the mobile organic liquid phase; a mechanism to introduce the mobile organic liquid phase to a buffer containing a plurality of substrates causing a series of biochemical reactions that create a change corresponding to a concentration of the target analyte; and a detector to perform real-time analysis that correlates to a concentration of the organic compounds to determine a presence of the target analyte.
- the collector may comprise a tube comprising silica gel coated with a xerogel to collect the organic compounds.
- the collector may comprise a microelectromechanical systems (MEMS) device to collect the organic compounds.
- MEMS microelectromechanical systems
- the system may comprise a reservoir to hold the mobile organic liquid phase; and a valve to control delivery of the mobile organic liquid phase into the collector, wherein the mobile organic liquid phase comprises a non-polar solvent.
- the non-polar solvent may comprise hexane.
- the system may comprise an alarm that is triggered upon detection of the presence of the target analyte above a predetermined level.
- Another embodiment provides an apparatus comprising a collector to collect a plurality of organic classes of compounds from an air sample; a micro-fluidic chamber to combine the collected plurality of organic classes of compounds with a biochemically and chemically reactive mobile phase analytic solution; and a detector to detect a presence of phosphate compounds in the mobile phase analytic solution.
- the apparatus may comprise a column containing a xerogel coated silica gel to collect the plurality of organic classes of compounds; and a heater to heat the column.
- the apparatus may comprise a MEMS device to collect the plurality of organic classes of compounds.
- the apparatus may comprise a microchannel reactor comprising immobilized acetylcholine esterase that is introduced to the collected plurality of organic classes of compounds and the mobile phase analytic solution.
- the detector may comprise a buffer to detect acetylcholine esterase activity and trigger a fluorescent-producing reaction and create a fluorophore upon detecting a presence of acetylcholine esterase that is inhibited by the phosphate compounds in the mobile phase analytic solution.
- the apparatus may comprise a light source to excite the fluorophore.
- the apparatus may comprise a photodiode to measure the fluorophore.
- the microchannel reactor may comprise a liquid chamber containing a drop-wise addition channel.
- Another embodiment provides a method comprising converting acetylcholine to acetate and choline; oxidizing the choline to derive betaine aldehyde and hydrogen peroxide; oxidizing the hydrogen peroxide to generate a hydrogen ion and electron; and generating a fluorophore from the hydrogen ion and electron.
- the method may comprise introducing an enzyme comprising any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase to the acetylcholine to convert the acetylcholine to acetate and choline.
- the method may comprise immobilizing the enzyme.
- the method may comprise oxidizing the hydrogen peroxide by a peroxidase.
- the method may comprise exciting the fluorophore to fluorescence.
- the method may comprise correlating the fluorescence to an inverse correlation of a concentration of organo-phosphates.
- FIG. 1 is a block diagram illustrating a gas-to-liquid transfer system, according to an embodiment herein;
- FIG. 2 A is a block diagram illustrating the collector of the gas-to-liquid transfer system of FIG. 1 with a tube, according to an embodiment herein;
- FIG. 2 B is a block diagram illustrating the collector of the gas-to-liquid transfer system of FIG. 1 with a MEMS device, according to an embodiment herein;
- FIG. 3 is a block diagram illustrating the gas-to-liquid transfer system of FIG. 1 with a reservoir and valve, according to an embodiment herein;
- FIG. 4 is a block diagram illustrating the gas-to-liquid transfer system of FIG. 1 with an alarm, according to an embodiment herein;
- FIG. 5 is a block diagram illustrating an apparatus to perform gas-to-liquid transfer, according to an embodiment herein;
- FIG. 6 A is a block diagram illustrating the apparatus of FIG. 5 with a column and heater, according to an embodiment herein;
- FIG. 6 B is a block diagram illustrating the apparatus of FIG. 5 with a MEMS device, according to an embodiment herein;
- FIG. 7 is a block diagram illustrating the apparatus of FIG. 5 with a microchannel reactor, according to an embodiment herein;
- FIG. 8 is a block diagram illustrating aspects of the detector of the apparatus of FIG. 5 , according to an embodiment herein;
- FIG. 9 is a block diagram illustrating the apparatus of FIG. 5 with a light source, according to an embodiment herein;
- FIG. 10 is a block diagram illustrating the apparatus of FIG. 5 with a photodiode, according to an embodiment herein;
- FIG. 11 is a block diagram illustrating aspects of the microchannel reactor of the apparatus of FIG. 5 , according to an embodiment herein;
- FIG. 12 A is a flow diagram illustrating a method of performing a chemical process, according to an embodiment herein;
- FIG. 12 B is a flow diagram illustrating a method of introducing an enzyme in the chemical process of FIG. 12 A , according to an embodiment herein;
- FIG. 12 C is a flow diagram illustrating a method of immobilizing an enzyme in the chemical process of FIG. 12 B , according to an embodiment herein;
- FIG. 12 D is a flow diagram illustrating a method of oxidizing the hydrogen peroxide in the chemical process of FIG. 12 A , according to an embodiment herein;
- FIG. 12 E is a flow diagram illustrating a method of exciting the fluorophore in the chemical process of FIG. 12 A , according to an embodiment herein;
- FIG. 12 F is a flow diagram illustrating a method of correlating a fluorescence in the chemical process of FIG. 12 A , according to an embodiment herein;
- FIG. 13 is a schematic representation of the chemical process of the method of FIG. 12 A , according to an embodiment herein;
- FIG. 14 A is a schematic diagram illustrating a microfluidic device, according to an embodiment herein;
- FIG. 14 B is a schematic diagram illustrating a chemical scheme of the enzyme immobilization structure, according to an embodiment herein;
- FIG. 14 C is a graphical representation that correlates the protein concentration as a function of flow rate, according to an embodiment herein;
- FIG. 14 D is a graphical representation that correlates the fluorescence intensity as a function of flow rate, according to an embodiment herein;
- FIG. 15 A is a graphical representation that illustrates the relative fluorophore intensity for various solvents, according to an embodiment herein;
- FIG. 15 B is a schematic diagram illustrating a microchannel reactor, according to an embodiment herein;
- FIG. 16 A is a schematic diagram illustrating a detector system, according to an embodiment herein;
- FIG. 16 B is a graphical representation that correlates the current (corresponding to the fluorescence) as a function of time, according to an embodiment herein;
- FIG. 17 is another graphical representation that correlates the current (corresponding to the fluorescence) as a function of time, according to an embodiment herein;
- FIG. 18 is a schematic diagram illustrating a gas-phase analyte to liquid-phase transfer system, according to an embodiment herein;
- FIG. 19 is a schematic diagram illustrating a vapor generation and sample delivery system for characterizing a gas sample collector using a diffusion vial and sample loop, according to an embodiment herein;
- FIG. 20 is a graphical representation that correlates the integrated area NPD signal from PC-released TBP as a function of collection time, according to an embodiment herein;
- FIG. 21 is a schematic diagram illustrating a gas-to-liquid transfer system, according to an embodiment herein;
- FIG. 22 is a graphical representation that correlates the concentration of TBP in hexane as a function of peak area, according to an embodiment herein;
- FIG. 23 is a schematic diagram illustrating a system for continuous operation of an air-to-liquid sampler, according to an embodiment herein.
- the embodiments herein provide a gas-to-liquid transfer system to detect the presence of contaminants such as organo-phosphate compounds, among others.
- a collector collects the air contaminants for transfer to a dual reaction liquid chamber liquid that adds a solvent, such as hexane, to the collected organo-phosphates.
- a detector is provided to detect the presence of phosphate compounds, for example, by introducing an enzyme such as acetylcholine esterase, cyclooxygenase, or horseradish peroxidase.
- the embodiments herein utilize fluorescence emissions or other detectors (i.e., electrochemical) to determine the presence of the contaminants.
- FIGS. 1 through 23 where similar reference characters denote corresponding features consistently throughout, there are shown exemplary embodiments.
- the size and relative sizes of components, layers, and regions may be exaggerated for clarity.
- FIG. 1 illustrates a system 10 comprising a pump 15 to deliver vapor 20 comprising airborne contaminants 25 comprising organic compounds 35 comprising a target analyte 30 .
- the system 10 may be a portable system that is sized to be placed and removed from aircraft or other environmental location where air detection is required.
- the pump 15 may comprise any of an electrical pump, mechanical pump, pneumatic pump, and electro-mechanical pump, or combinations thereof.
- the airborne contaminants 25 may comprise a plurality of different types of contaminants.
- the organic compounds 35 may comprise any of organo-phosphate compounds, opioids, cannabinoids, and other classes of organic compounds.
- the target analyte 30 may be selected based on a predetermined classification of target analytes that are desired to be detected and analyzed. Accordingly, the target analyte 30 comprises a chemical signature that the system 10 is configured to detect and analyze based on predetermined and/or pre-programmed chemical signature properties that are to be compared against to determine if there is a match, and the level of contamination or concentration of the target analyte 30 in the vapor 20 .
- the system 10 further comprises a collector 40 to transfer the airborne contaminants 25 by autonomous liquid extraction into a mobile organic liquid phase 45 .
- the collector 40 may comprise a gas-to-liquid collector that utilizes collection gels, beads, or other mechanisms to collect the airborne contaminants 25 for transfer by liquid extraction.
- the mobile organic liquid phase 45 may flow at any suitable rate necessary to carry the liquid phase of the airborne contaminants 25 and corresponding organic compounds 35 .
- the mobile organic liquid phase 45 may comprise a non-polar solvent 110 .
- the non-polar solvent 110 may comprise hexane or any other suitable non-polar material.
- the system 10 comprises a micro-fluidic chamber 50 comprising immobilized biorecognition elements 52 that bind to analytes 46 delivered from the mobile organic liquid phase 45 .
- the biorecognition elements 52 may be natural or synthetic.
- the biorecognition elements 52 may include antibody enzymes, nucleic acid aptamers, or molecularly imprinted polymers. Unbound biorecognition elements 52 (i.e., free of the target analyte 30 ) compared to biorecognition elements 52 bound with target analytes 30 enable detection.
- reagents are added in an aqueous phase (e.g., oil in water droplet) to trigger reactions needed for detection of the target analyte 30 .
- the reagents may include Amplex® red reagent, among others.
- the micro-fluidic chamber 50 may contain a micro-preconcentrator ( ⁇ -PC) device (not shown in FIG. 1 ) to control the concentration levels of the organic compounds 35 to be utilized for testing and analysis in the system 10 .
- the micro-fluidic chamber 50 and the ⁇ -PC device may be used to increase the concentration of the organic compounds 35 (and thus, the target analytes 30 ) from a lower concentration to a higher concentration.
- the system 10 may comprise a mechanism 55 to introduce the mobile organic liquid phase 45 to a buffer 60 containing a plurality of substrates 65 causing a series of biochemical reactions that create a change corresponding to a concentration of the target analyte 30 .
- the mobile organic liquid phase 45 may be introduced by drop-wise addition, and thus the mechanism 55 may be any suitable device, such as a mechanical dropper, that transfers the mobile organic liquid phase 45 to the buffer 60 .
- the buffer 60 may be any suitable type of buffering solution to control some of the chemical properties associated with the mobile organic liquid phase 45 , such as the acidity, etc.
- the buffer 60 may comprise any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase reacting with the acetylcholine to convert the acetylcholine to acetate and choline.
- the plurality of substrates 65 may comprise any suitable type of chemical material or molecules upon which the enzymes in the mobile organic liquid phase 45 act including bonding.
- the system 10 further comprises a detector 70 to perform real-time analysis 75 that correlates to a concentration of the organic compounds 35 to determine a presence of the target analyte 30 .
- the detector 70 may comprise a photodetector configured to detect of fluorescence emission.
- the detector 70 may comprise any of an electronic, electrochemical, plasmonic, surface plasmon resonance, absorption, emission, electron transfer, and charge transfer device, or combinations thereof, or any other suitable detection system.
- the detector 70 may comprise a processor or may be communicatively linked to a processor, computer, or server device(s) to perform the real-time analysis 75 of the organic compounds 35 in order to determine the presence of the target analyte 30 .
- the analytes of interest e.g., target analyte 30
- the analytes of interest can interact with the biorecognition elements 52 , freeing them from the surface of a microreactor. These biorecognition elements 52 can then be detected downstream using the detector 70 with or without capture.
- FIG. 2 A illustrates that the collector 40 may comprise a tube 80 comprising silica gel 85 coated with a xerogel 90 to collect the organic compounds 35 .
- the tube 80 may comprise any suitable size or material such as glass or durable plastic, for example.
- the silica gel 85 coated with the xerogel 90 may comprise solid pellets that are positioned in the tube 80 .
- the silica gel 85 may comprise viscous gel or material with the xerogel 90 coated thereon, and which are positioned in the tube 80 . Accordingly, the embodiments herein are not restricted to any particular configuration of the silica gel 85 and/or xerogel 90 .
- FIG. 2 B with reference to FIGS.
- the collector 40 may comprise a MEMS device 95 to collect the organic compounds 35 .
- MEMS device/system that could be used for the MEMS device 95 herein is described in Bae, B., et al., “A Fully-Integrated MEMS Preconcentrator for Rapid Gas Sampling,” U.S. Air Force Report AFRL-PR-WP-TP-2007-224 for submission of a Conference paper submitted to the Proceedings of the Transducers 2007 Conference, Mar. 19, 2007, pp. 1-4, the complete disclosure of which, in its entirety, is herein incorporated by reference.
- FIG. 3 illustrates that the system 10 may comprise a reservoir 100 to hold the mobile organic liquid phase 45 .
- the reservoir 100 may be any suitable type of liquid chromatographic instrument that may be configured to retain the mobile organic liquid phase 45 .
- the reservoir may be configured to contain pressurized solvent and may comprise vacuum connections for drawing the mobile organic liquid phase 45 therefrom and/or thereto.
- the system 10 may comprise a valve 105 to control delivery of the mobile organic liquid phase 45 into the collector 40 .
- the valve 105 may comprise any suitable type of electrical, mechanical, pneumatic, or electro-mechanical valve, or combinations thereof. Moreover, the valve 105 may be automatically controlled by a local or remote processor or controller (not shown) or controlled by user intervention, as necessary.
- FIG. 4 illustrates that the system 10 may comprise an alarm 115 that is triggered upon detection of the presence of the target analyte 30 above a predetermined level.
- the alarm 115 may comprise any of an audio alarm, visual alarm, or combinations thereof.
- the alarm 115 may be communicatively coupled to the detector 70 and/or a processor or computer that transmits a signal to the alarm 115 upon the detector 70 detecting the presence of the target analyte 30 above a pre-programmed predetermined level. Since the detection and analysis of the presence of the target analyte 30 occurs in real-time, the alarm 115 is also triggered in real-time to alert users (i.e., pilots or other aircraft personnel, for example) to exit the aircraft or otherwise take precautionary measures to protect themselves from a potentially toxic environment due to the presence of the target analyte 30 . Moreover, the alarm 115 may comprise variable outputs based on the level of the presence of the target analyte 30 .
- a yellow light may be output to indicate the presence of the target analyte 30 at levels that are not considered immediate health threats.
- a red light may be output to indicate a significant health threat to personnel in the vicinity of the system 10 and vapor 20 .
- the variable outputs may be audio-based with different pitches, tones, or frequencies depending on the level of the threat that is detected.
- the audio output from the alarm 115 may be a computer-generated voice providing instructions for personnel as well as outputting the type of target analyte 30 that has been detected as well as the level (i.e., amount) of detection.
- FIG. 5 illustrates another embodiment that provides an apparatus 150 comprising a collector 40 to collect a plurality of organic classes of compounds 155 from an air sample 160 .
- the apparatus 150 may be miniaturized to be portable and easily transferred from various settings such as aircraft, for example.
- the plurality of organic classes of compounds 155 may comprise any of organo-phosphate compounds, opioids, cannabinoids, and other classes of organic compounds, according to some examples.
- the air sample 160 may be the ambient air in an aircraft cockpit, for example. However, the air sample 160 and corresponding environmental location for using the apparatus 150 may be any suitable location where the detection and analysis of the air sample 160 is required.
- the apparatus 150 comprises a micro-fluidic chamber 50 to combine the collected plurality of organic classes of compounds 155 with a biochemically and chemically reactive mobile phase analytic solution 170 (e.g., which may be the buffer 60 containing the plurality of substrates 65 , for example). According to an example, single or multiple pairs of immiscible liquids may extract and transfer contaminants to the biochemically and chemically reactive mobile phase analytic solution 170 .
- the apparatus 150 further comprises a detector 70 to detect a presence of phosphate compounds 175 in the mobile phase analytic solution 170 .
- the mobile phase analytic solution 170 may be any suitable type of buffering solution to control chemical properties, and may contain any suitable type of chemical material or molecules upon which enzymes act, including bonding.
- the mobile phase analytic solution 170 may comprise the mobile organic liquid phase 45 , described above, of the collected plurality of organic classes of compounds 155 .
- FIG. 6 A illustrates that the apparatus 150 may comprise a column 180 containing a xerogel 90 coated silica gel 85 to collect the plurality of organic classes of compounds 155 .
- the column 180 may comprise any suitable size or material such as glass or durable plastic, for example.
- the silica gel 85 is coated with the xerogel 90 and may comprise solid pellets that are positioned in the column 180 .
- the silica gel 85 may comprise viscous gel or material with the xerogel 90 coated thereon, and which are positioned in the column 180 .
- the column 180 may be configured to withstand pressured liquids including the mobile phase analytic solution 170 , the mobile organic liquid phase 45 , or other liquids, solvents, or solutions.
- the apparatus 150 may comprise a heater 185 to heat the column 180 .
- the heater 185 may comprise any suitable type of heater 185 that can be automatically and/or manually controlled to heat the column 180 to desired temperatures.
- the heater 185 may be used to heat to the column 180 to help facilitate a separation process of the mobile phase analytic solution 170 .
- FIG. 6 B illustrates that the apparatus 150 may comprise a MEMS device 95 to collect the plurality of organic classes of compounds 155 .
- FIG. 7 illustrates that the apparatus 150 may comprise a microchannel reactor 190 comprising immobilized acetylcholine esterase 195 or other alternative selective enzyme or aptamer that is inhibited by the phosphate compounds 175 that is introduced to the collected plurality of organic classes of compounds 155 and the mobile phase analytic solution 170 .
- the microchannel reactor 190 may comprise a continuous plug flow reactor, although other types of reactors may be utilized in accordance with the embodiments herein.
- the microchannel reactor 190 may comprise a series of serpentine channels in which the chemical reactions of the mobile phase analytic solution 170 occur. Moreover, the microchannel reactor 190 may be configured to have suitable heat exchange thermal properties to withstand exothermic reactions of the mobile phase analytic solution 170 .
- FIG. 8 illustrates that the detector 70 may comprise a buffer 60 .
- the buffer 60 may comprise any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase reacting with the acetylcholine to convert the acetylcholine to acetate and choline.
- the buffer 60 is to detect acetylcholine esterase activity and trigger a fluorescent-producing reaction and create a fluorophore 200 upon detecting a presence of acetylcholine esterase 195 that is inhibited by the phosphate compounds 175 in the mobile phase analytic solution 170 resulting in a quenching of the enzyme comprising any of the acetylcholine esterase, cyclooxygenase, and horseradish peroxidase.
- the fluorophore 200 may be any suitable type of fluorescent chemical compound capable of re-emitting light upon excitation caused by the reaction of the buffer 60 .
- FIG. 9 illustrates that apparatus 150 may comprise a light source 205 to excite the fluorophore 200 .
- the light source 205 may comprise a light-emitting diode (LED) or any other suitable light generating and emitting device.
- FIG. 10 illustrates that apparatus 150 may comprise a photodiode 210 to measure the fluorophore 200 .
- the photodiode 210 may be configured to measure the light emitted by the fluorophore 200 and convert the light into an electrical current.
- the concentration of the phosphate compounds 175 is inversely proportional to the excitation of the fluorophore 200 , which indicates the presence of the toxins (based on a predetermined chemical signature as described above) from the plurality of organic classes of compounds 155 in the air sample 160 .
- FIG. 11 illustrates that microchannel reactor 190 may comprise a liquid chamber 215 containing a drop-wise addition channel 220 , according to an example.
- the liquid chamber 215 and drop-wise addition channel 220 may be any suitable devices and instruments capable of retaining and transferring the aforementioned solvents and solutions used in the apparatus 150 .
- FIG. 12 A is a flow diagram illustrating a method 300 according to an embodiment herein.
- FIG. 13 illustrates a schematic representation of the chemical process described by the method 300 .
- the method 300 comprises converting ( 305 ) acetylcholine to acetate and choline; oxidizing ( 310 ) the choline to derive betaine aldehyde and hydrogen peroxide; oxidizing ( 315 ) the hydrogen peroxide to generate a hydrogen ion and electron; and generating ( 320 ) a fluorophore 200 from the hydrogen ion and electron.
- FIG. 12 B with reference to FIGS.
- FIG. 1 through 12 A is a flow diagram illustrating that the method 300 may comprise introducing ( 325 ) an enzyme comprising any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase to the acetylcholine to convert the acetylcholine to acetate and choline.
- FIG. 12 C is a flow diagram illustrating that the method 300 may comprise immobilizing ( 330 ) the enzyme.
- FIG. 12 D is a flow diagram illustrating that the method 300 may comprise oxidizing ( 335 ) the hydrogen peroxide by a peroxidase.
- FIG. 12 E is a flow diagram illustrating that the method 300 may comprise exciting ( 340 ) the fluorophore 200 to fluorescence.
- FIG. 12 F is a flow diagram illustrating that the method 300 may comprise correlating ( 345 ) the fluorescence to an inverse correlation of a concentration of organo-phosphates.
- AChE is an important enzyme that breaks down acetylcholine, a key substance as a neurotransmitter.
- Organo-phosphates are toxic because they inhibit AChE activity by binding on the active site of AChE covalently.
- the embodiments herein provide an inhibition mechanism to detect the organo-phosphate in the air, as depicted in FIG. 13 , with reference to FIGS. 1 through 12 F .
- Reaction 1 is a degradation reaction that converts acetylcholine to acetate and choline with AChE.
- Reaction 2 is an oxidation reaction of choline in which betaine aldehyde and hydrogen peroxide are derived, and the hydrogen peroxide is oxidized by peroxidase to generate hydrogen ion and electron.
- the hydrogen and electron activate the fluorescence substrate.
- the fluorescence is excited at 550 nm and 600 nm light is emitted.
- the microchannel reactor 190 may comprise a serpentine microfluidic channel 401 as depicted in FIG. 14 A , and which may be fabricated by soft-lithography processing.
- soft-lithography is used to make the mold, and white polydimethylsiloxane (PDMS, 1:10 ratio of cross linker and monomer) 403 is cured on the mold at 70° C. after spin coating at 250 RPM.
- the microfluidic channel 401 formed by soft-lithography is then covered with a transparent slab of PDMS 403 .
- the surface of the microfluidic channel 401 is exposed to UV-plasma to generate hydroxyl groups on the surface, to allow functionalization with amine groups via (3-aminopropyl) triethoxylane (3-APTES).
- Acetone and 3-APTES are mixed at a 7:3 ratios, and injected into the microfluidic channel 401 at a 100 ⁇ L/min flow rate at approximately 60° C. for approximately 4 hours.
- a cross-linker is developed using glutaraldehyde at a 6:4 ratio of PBS (phosphate buffer saline) and glutaraldehyde mixture (glutaraldehyde 10% in PBS) and injected at ⁇ 50 ⁇ L/min flow rate for approximately 4 hours.
- FIG. 14 B shows the chemical scheme of the enzyme immobilization structure 407 on the PDMS 403 .
- the prepared microchannel reactor 190 is filled with PBS and stored at approximately 4° C.
- the chain reaction using the microchannel reactor 190 is performed with reactant mixtures of acetylcholine ( ⁇ 100 ⁇ M) and fluorescence substance ( ⁇ 5 ⁇ L) as the mixture is injected into the microchannel reactor 190 at ⁇ 200 ⁇ L/min flow rate at approximately 30° C. Fluorescence from the reaction is excited at ⁇ 550 nm wavelength (green light), and emitted at ⁇ 600 nm (orange light).
- the microchannel reactor 190 is prepared as all enzymes are immobilized on the surface of the channel 401 .
- the cross-linker quantity and enzyme binding amount are controlled by changing functionalization time and flow rate.
- FIG. 14 C depicts the flow rate results.
- High enzyme immobilization level leads to high enzyme activity in the microchannel reactor 190 . Excessively high activity, however, leads to saturation in the fluorescence intensity, and such high activity can dilute the effect of organo-phosphate inhibition. Such competitive inhibition is usually solved with excessive enzyme amount. Thus, an appropriate enzyme amount should be immobilized to for high sensitivity of organo-phosphate inhibition.
- the quantity of cross-linker can be varied. For high sensitivity of inhibition response, the functionalization time is determined at over 2 hours.
- the flow rate for enzyme immobilization is ⁇ 30 ⁇ L/min as denoted by the dashed box in FIG. 14 C . If a high level of protein is immobilized, the sensitivity decreases. A flow rate of 30 ⁇ L/min yields an appropriate reaction rate. Fluorescence is very sensitive, and it shows reasonable intensity with ⁇ mon concentration level of acetylcholine. When the flow rate is ⁇ 30 ⁇ L/min, the relative fluorescence intensity is ⁇ 75% of saturated intensity as indicated in the results of FIG. 14 D .
- the collector 40 may be an air-to-liquid (gas-to-liquid) tributyl phosphate (TBP) collector 40 .
- the TBP collection may include a gas-to-liquid extractor that is utilized in a laboratory hood. A beaker containing ⁇ 10 mL TBP is placed adjacent to a probe on the TBP collector 40 . The collector 40 sniffs TBP, and the membrane is rinsed with hexane. The TBP on the membrane dissolves in hexane, and finally the TBP can be collected in a 1 mL syringe for injection into the reaction-detection system.
- the microchannel reactor 190 is experimentally tested with non-polar organic solvents.
- the elute of sensor system includes solvents.
- the reactant with fluorescence substrate is, however, a water-based solution.
- droplet generating microfluidics is introduced.
- various solvents are experimentally considered in terms of conservation of enzyme in the microchannel reactor 190 activity as denoted by the relative fluorophore intensity.
- Hexane is experimentally determined to be an appropriate solvent for both the gas-to-liquid TPB collector 40 and the microchannel reactor 190 .
- the drop-wise addition channel 220 may also be embedded in the microchannel reactor 190 .
- FIG. 15 B shows an experimental configuration of the microchannel reactor 190 .
- Continuous flow reaction was conducted using the microchannel reactor 190 prepared with the optimum conditions of an enzyme immobilization and organic solvent/water hybrid flow system.
- the fluorescence is observed from a cuvette 209 (denoted in FIG. 16 A ) in which the fluorescence substrate is connected with the product of the enzyme reaction to generate fluorescence luminescence.
- the fluorescence is observed at ⁇ 600 nm wavelength, excited at 550 nm wavelength.
- an inhibition substrate e.g., TBP
- Reactant flow rate also affects the inhibition, and the flow rate is determined to be ⁇ 50 ⁇ L/min.
- the fluorescent intensity is observed to decrease.
- the competitive inhibition of TBP is direct, and the signal of fluorescence changes instantly.
- the schematic configuration of the detector 70 is shown in FIG. 16 A .
- Various geometries may be considered for effective detection of fluorescence emission in the micro-channel reactor 190 and structures for direct lighting-detecting are determined.
- the detector 70 size should be miniaturized to allow integration with the micro-fluidic chamber 50 .
- millimeter-sized components are used.
- An excitation light source 205 to generate light 206 may comprise an LED 207 and a polarizing filter 208 .
- a cuvette 209 is positioned in the pathway of the light 206 . Green filters may be used to reject stray light and excitation light.
- the current from the photodetector 70 is measured using a digital multi-meter (DMM) 204 .
- DMM digital multi-meter
- the detector 70 determines the fluorescence intensity associated with continuous reactant flow.
- the continuous changes in current are recorded and stored in a computer 203 .
- the noise from the recorded data may be removed by adjusting a low pass digital filter as part of the data processing.
- the fluorescence intensity is detected after emission of the light.
- the detector 70 mechanism is based on a fluorescence microscope. Green LEDs (550 nm) are selected and tested as excitation light sources with small sizes and strong output intensity. The photodetectors 70 should be sensitive at near red color light.
- the Polarizing filter 208 rejects all wavelengths below the emission wavelength. 570 nm and 590 nm filters are experimentally tested, and a high quality of wavelength rejection is realized with a 610 nm polarizing filter 208 . Emission of the fluorescence substrate is known to be 600 nm, but a small size of the detected signal creates challenges in eliminating effects of light scattering penetration of excitation light 206 through the polarizing filter 208 .
- FIG. 16 B summarizes the results. Time 0 is the starting point of inhibition and at ⁇ 200 pM TBP, the fluorescence changes as shown in FIG. 16 B .
- the current scale is around nA before optimization.
- FIG. 16 B shows results at the ⁇ A scale, which is significantly improved in terms of sensitivity and stability for actual use.
- the developed sensing-detecting system should be integrated with the TBP collector 40 .
- the experimental organo-phosphate detection system was designed and tested at the bread board level.
- the normal state of the system shows normal reaction conditions in which the chain reaction is performed.
- the chain reaction leads to the production of hydrogen which activates the fluorescence substrate ( FIG. 13 ).
- the system shows fluorescence intensity corresponding to acetylcholine concentration, and the fluorescence intensity is affected by acetylcholine concentration and AChE activity.
- the system has continuous flow while it is operated. During flow operation, there is a constant amount of acetylcholine (10 mM) and fluorescence substrate (50 ⁇ l/mL).
- AChE activity affects the fluorescence intensity and if there is a strong inhibitor in the elute, AChE activity will be decreased.
- the normal state of the system therefore, should show constant intensity of fluorescence.
- the alternating flow of hexane and reactant by the droplet generator for merging two flows is read out by the fluorescence detector 70 in FIG. 16 A .
- a strong pink color indicated that the enzyme chain reactions are in the stationary phase.
- the TPB collector 40 is operated and TBP in the air could be collected and resolved into hexane.
- the system is a batch type and the TBP could be recovered by hexane flushing by two syringes. When the syringe with collected TBP is injected into the system, the reaction is inhibited.
- FIG. 17 shows the results of all experimental system operations.
- the fluorescence detector 70 generates current as there is over 610 nm light in the detector channel, and the signal data is the current value.
- the reaction system was stationary phase by ⁇ 400 sec.
- the constant fluorescence intensity reflects normal enzymatic activity.
- the signal decreases which means that inhibition of AChE occurs by the TBP collected from air.
- the dashed adjoint line in FIG. 17 is filtered data which results from low pass filter adjustment.
- the decreased rate can be calculated to derive TBP concentration.
- the level of decreasing rate will be different. A high amount of organo-phosphate would lead to a more rapid decrease in fluorescence intensity.
- the calibration of decrease rate should be conducted for practical use. It is noted that enzyme activity can deactivate naturally as it is used. The deactivation without the presence of organo-phosphates should be addressed to yield stable operation in practical conditions. The effect is expected not to be significant, and it would be a slight change of the intensity. Therefore, the system should have a reference reactor which only has the flow of the reactant and fluorescence substrate. The reference reactor would improve the sensitivity and reliability of the system. Also, an automated data processing system could be developed for practical use in situ.
- FIG. 18 An exemplary TBP detection system 500 that was experimentally tested is illustrated in FIG. 18 .
- the system 500 comprises an AChE reservoir 502 operatively connected to an air-to-liquid micro-preconcentrator ( ⁇ -PC) 506 .
- An air sample inlet 508 inputs into the ⁇ -PC 506 also.
- An air sample vacuum pump 510 is operatively connected to the ⁇ -PC 506 .
- a microchannel reactor substrate 520 is operatively connected to the ⁇ -PC 506 .
- the microchannel reactor 520 comprises a transparent substrate cover 514 , a LED light source 516 , and a charge-coupled device (CCD) 518 as a photodiode for sensing emitted light.
- CCD charge-coupled device
- An enzyme reservoir 504 and waste reservoir 522 are operatively connected to the microchannel reactor substrate 520 .
- a vacuum pump 512 for AChE transfer is operatively connected to the waste reservoir 522 .
- a low-concentration mix of TBP in air passes over the ⁇ -PC 506 where TBP is collected.
- the ⁇ -PC 506 rapidly heats to develop a concentrated pulse of TBP vapor in a small chamber that encloses the ⁇ -PC 506 .
- a portion of the concentrated pulse accumulates in solvent on the opposite side of a membrane that forms one wall of the chamber.
- the elevated concentration and temperature enhance the transfer of TBP into solvent.
- Solvent with the collected TBP is transferred to the detector, where it is incubated with an immobilized acetylcholine esterase within a microchannel reactor 520 .
- Aqueous solution for detection of acetylcholine esterase activity then passes over the immobilized enzyme, triggering a reaction producing a fluorescent substrate only if acetylcholine esterase is present and uninhibited by organophosphates/nerve agents.
- the LED light source 516 at 550 nm excites the fluorophore, and the emission is measured at 600 nm on a photodiode (CCD) 518 . The percent reduction of fluorescence correlates with the concentration of TBP in the sample.
- CCD photodiode
- Hexane is brought into direct contact with the xerogel in the ⁇ -PC 506 material.
- a pair of valves may be used to direct air and liquid flows during the sample collection cycle and the flush cycle where TBP is transferred to hexane. Between collection cycles, the ⁇ -PC 506 material is heated and dried with air.
- TBP is placed in a diffusion vial and set in a heated chamber with continuous 100 mL/min flow of zero air.
- the flux rate from the vial is determined gravimetrically by weekly weight measurements. With a D size diffusion vial with a 1-inch stem at ⁇ 80° C., the flux rate is determined to be 317 ng/min. This correlates with the estimated 390-ng/min flux rate for this vial. Since the sweep gas is 100 mL/min, the maximum concentration that can be delivered is approximately 400 ppb.
- the system 500 has a 500- ⁇ L sample loop so 2-ng of sample can be delivered to the test chamber shown in FIG. 19 . Sample loops of 100 ⁇ L and 10 ⁇ L can also be used, and the sample stream could also be diluted to deliver lower concentrations of TBP samples.
- the vapor system 500 was used to test some of the air-to-liquid sample collector concepts, but testing was also conducted with headspace samples of TBP in an open container.
- the upper limit can be determined by comparing the vapor pressure of TBP at ambient temperatures to the ambient pressure. At 25° C. the vapor pressure of TBP is on the order of 0.00113-mmHg.
- the barometric pressure is nominally 640-mmHg, so the concentration in the headspace is approximately 1.8-ppm.
- the concentration could be at least an order of magnitude lower as indicated in Skene, W., et al. “Vapor Pressure of Tri-n-Butyl Phosphonate,” J. Chem.
- the roll of the ⁇ -PC 506 in the system 500 is to capture the TBP in the air and concentrate it for delivery to the liquid.
- a series of tests were conducted to quantify the TBP capture and release properties for the ⁇ -PC 506 .
- the high-surface area ⁇ -PC 506 is first exposed to the TPB stream and then the valve is switched to connect the ⁇ -PC 506 to a nitrogen phosphorous detector (NPD). Voltage is applied to a heater on the ⁇ -PC 506 to produce a concentrated plume on analyte on the NPD.
- FIG. 20 shows that the integrated area NPD signal trace is proportional to the mass of TBP that flows to the detector.
- the mass collected is proportional to the collection time, at least up to 5 minutes. Further testing shows that the linearity falters at long collection times. At 15 minutes, the measured total peak area is about 75% of the linear predicted area.
- the ability of the ⁇ -PC 506 to retain a sample of TBP is also tested. Even with warm nitrogen blowing over the surface of the ⁇ -PC 506 for 4 extra minutes, there is no apparent loss in captured TBP. Certainly, longer intervals and higher flushing volumes will remove the TBP, but the xerogel coating has a high affinity for TBP to prevent quick loss in the captured TBP.
- the system is calibrated with a 500- ⁇ L sampling loop.
- This loop replaces the ⁇ -PC 506 to introduce a known quantity of analyte to the NPD.
- the TBP sample is generated with a D-sized diffusion vial in an oven at 80° C.
- the flux rate of TBP is estimated to be 393 ng/min.
- the flow rate of the zero-air sweep gas through the diffusion vial chamber is measured with a bubble meter to be 55.1 mL/min. Based on these measurements, the concentration of TBP in the stream is 7.16 ng/mL, so a 500- ⁇ L sample loop would contain 3.58 ng of TBP.
- FIG. 21 An experimental apparatus shown in FIG. 21 was developed where the preconcentrator is a bed of microbeads 550 that are coated with xerogel.
- the microbeads 550 are packed in a tube that is wrapped with a heater for drying the packed bed after the hexane extraction. Valves 552 , 553 at each end of the tube isolate the air collection system from the hexane.
- valves 552 , 553 are energized and a pump 555 pulls TBP-contaminated air through the microbeads 550 .
- the pump 555 is switched off and the valves 552 , 553 are de-energized.
- Hexane is introduced into the upstream side of the microbeads 550 using a 1-mL syringe 554 . The hexane is then withdrawn through the same port and transferred to a detector system. A second syringe of clean hexane is flushed in and out of the collection tube to remove TBP remaining on the microbeads 550 .
- valves 552 , 553 are then switched on, and the pump 555 and heaters are also switched on.
- the PC tube is heated to 60° C. to vaporize any remaining hexane. At this temperature, all hexane is removed in less than five minutes.
- the micro-bead packed PC system is tested to determine the concentration of TBP in the solvent.
- the original calibration is performed with acetonitrile, but the calibration is repeated with the hexane solvent and NPD.
- Five concentrations are run from 2 ⁇ g TBP/Liter hexane to 1000 ⁇ g/L, and the correlation between the area of the TBP peak and the concentration is shown in FIG. 22 .
- Tests were performed where TBP in air was drawn into the collector from the headspace above the surface of liquid TBP. After a collection of 25 minutes, 1 mL of hexane is injected into the ⁇ -PC 506 and withdrawn from the same port. When 1-4, of this sample is injected into the calibrated flame ionization detector (FID), the peak area corresponds to 4.8 ng of TBP in the sample. A second flush 1-mL of hexane in the ⁇ -PC 506 shows that the concentration goes to 8.4 ng of TBP, but a third flush of hexane shows that the ⁇ -PC 506 is clean. Similar tests are performed at 5 and 10-minute collect times.
- FIG. 23 illustrates one exemplary approach for automating the collector and detector in the system.
- pump 1 and valve 1 are energized to pull an air sample into the collector.
- Check valves at the inlet of the ⁇ -PC trap only allows the flow to come from one port of a tee at the inlet.
- pump 2 and valve 2 energize to flush hexane back through the ⁇ -PC trap.
- a check valve at the inlet tee directs the flow to the detector system.
- valve 2 de-energizes, and air pushes remaining hexane out of the trap.
- pump 1 , valve 1 , and the heater can be activated to dry the trap before the next collection cycle.
- the experiments demonstrate an organo-phosphates detection system based on an inhibition mechanism for acetylcholinesterase.
- a microchannel reactor 190 with chain reaction to yield fluorescence is experimentally demonstrated and a detection sub-system is constructed to readout the fluorescence intensity.
- the gas-to-liquid TBP collector 40 gathers TBP in the air, and transfers it to the liquid (hexane), which is injected into the enzymatic reaction microchannel reactor 190 .
- the detector 70 allows sensing of changes in the reaction rate by measuring the inverse proportionality to organo-phosphate concentration to fluorescence.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Clinical Laboratory Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Mechanical Engineering (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
A system, apparatus, and method include a pump to deliver vapor including airborne contaminants including organic compounds including a target analyte; a collector to transfer the airborne contaminants by autonomous liquid extraction into a mobile organic liquid phase; a micro-fluidic chamber including immobilized biorecognition elements that bind to analytes delivered from the mobile organic liquid phase; a mechanism to introduce the mobile organic liquid phase to a buffer containing a plurality of substrates causing a series of biochemical reactions that create a change corresponding to a concentration of the target analyte; and a detector to perform real-time analysis that correlates to a concentration of the organic compounds to determine a presence of the target analyte.
Description
- This application is a division of U.S. application Ser. No. 16/379,890 filed Apr. 10, 2019 and issued as U.S. Pat. No. 11,548,001 on Jan. 10, 2023, which claims the benefit of and priority to U.S. Provisional Patent Application No. 62/655,478 filed on Apr. 10, 2018. The specifications of these applications are incorporated herein by reference, each in its entirety.
- The invention described herein may be manufactured and used by or for the Government of the United States for all government purposes without the payment of any royalty.
- The embodiments herein generally relate to contaminant detectors, and more particularly to detectors of organo-phosphate compounds, opioids, cannabinoids, and other classes of organic compounds.
- There is a gap in surveillance in military and civilian operations. For example, there is concern with the air quality in aircraft for exposure to organo-phosphates that are found in fluids used by aircraft; specifically, tri-cresyl phosphates. There have been numerous attempts to measure these substances, but the methodology generally requires sampling and submission to a laboratory, which does not permit real-time analysis. Furthermore, the existing methodologies typically require substantial dilutions of the samples that elevates the detection limit to μg/sample. Another group of toxic organo-phosphates are pesticides and nerve agents. Due to the extreme toxicity of these agents it would be desirable to detect the substances at the femtogram level, and develop equipment that can operate autonomously and record data in real-time.
- In view of the foregoing, an embodiment herein provides a system comprising a pump to deliver vapor comprising airborne contaminants comprising organic compounds comprising a target analyte; a collector to transfer the airborne contaminants by autonomous liquid extraction into a mobile organic liquid phase; a micro-fluidic chamber comprising immobilized biorecognition elements that bind to analytes delivered from the mobile organic liquid phase; a mechanism to introduce the mobile organic liquid phase to a buffer containing a plurality of substrates causing a series of biochemical reactions that create a change corresponding to a concentration of the target analyte; and a detector to perform real-time analysis that correlates to a concentration of the organic compounds to determine a presence of the target analyte.
- The collector may comprise a tube comprising silica gel coated with a xerogel to collect the organic compounds. The collector may comprise a microelectromechanical systems (MEMS) device to collect the organic compounds. The system may comprise a reservoir to hold the mobile organic liquid phase; and a valve to control delivery of the mobile organic liquid phase into the collector, wherein the mobile organic liquid phase comprises a non-polar solvent. The non-polar solvent may comprise hexane. The system may comprise an alarm that is triggered upon detection of the presence of the target analyte above a predetermined level.
- Another embodiment provides an apparatus comprising a collector to collect a plurality of organic classes of compounds from an air sample; a micro-fluidic chamber to combine the collected plurality of organic classes of compounds with a biochemically and chemically reactive mobile phase analytic solution; and a detector to detect a presence of phosphate compounds in the mobile phase analytic solution. The apparatus may comprise a column containing a xerogel coated silica gel to collect the plurality of organic classes of compounds; and a heater to heat the column.
- The apparatus may comprise a MEMS device to collect the plurality of organic classes of compounds. The apparatus may comprise a microchannel reactor comprising immobilized acetylcholine esterase that is introduced to the collected plurality of organic classes of compounds and the mobile phase analytic solution. The detector may comprise a buffer to detect acetylcholine esterase activity and trigger a fluorescent-producing reaction and create a fluorophore upon detecting a presence of acetylcholine esterase that is inhibited by the phosphate compounds in the mobile phase analytic solution. The apparatus may comprise a light source to excite the fluorophore. The apparatus may comprise a photodiode to measure the fluorophore. The microchannel reactor may comprise a liquid chamber containing a drop-wise addition channel.
- Another embodiment provides a method comprising converting acetylcholine to acetate and choline; oxidizing the choline to derive betaine aldehyde and hydrogen peroxide; oxidizing the hydrogen peroxide to generate a hydrogen ion and electron; and generating a fluorophore from the hydrogen ion and electron. The method may comprise introducing an enzyme comprising any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase to the acetylcholine to convert the acetylcholine to acetate and choline. The method may comprise immobilizing the enzyme. The method may comprise oxidizing the hydrogen peroxide by a peroxidase. The method may comprise exciting the fluorophore to fluorescence. The method may comprise correlating the fluorescence to an inverse correlation of a concentration of organo-phosphates.
- These and other aspects of the embodiments herein will be better appreciated and understood when considered in conjunction with the following description and the accompanying drawings. It should be understood, however, that the following descriptions, while indicating preferred embodiments and numerous specific details thereof, are given by way of illustration and not of limitation. Many changes and modifications may be made within the scope of the embodiments herein without departing from the spirit thereof, and the embodiments herein include all such modifications.
- The embodiments herein will be better understood from the following detailed description with reference to the drawings, in which:
-
FIG. 1 is a block diagram illustrating a gas-to-liquid transfer system, according to an embodiment herein; -
FIG. 2A is a block diagram illustrating the collector of the gas-to-liquid transfer system ofFIG. 1 with a tube, according to an embodiment herein; -
FIG. 2B is a block diagram illustrating the collector of the gas-to-liquid transfer system ofFIG. 1 with a MEMS device, according to an embodiment herein; -
FIG. 3 is a block diagram illustrating the gas-to-liquid transfer system ofFIG. 1 with a reservoir and valve, according to an embodiment herein; -
FIG. 4 is a block diagram illustrating the gas-to-liquid transfer system ofFIG. 1 with an alarm, according to an embodiment herein; -
FIG. 5 is a block diagram illustrating an apparatus to perform gas-to-liquid transfer, according to an embodiment herein; -
FIG. 6A is a block diagram illustrating the apparatus ofFIG. 5 with a column and heater, according to an embodiment herein; -
FIG. 6B is a block diagram illustrating the apparatus ofFIG. 5 with a MEMS device, according to an embodiment herein; -
FIG. 7 is a block diagram illustrating the apparatus ofFIG. 5 with a microchannel reactor, according to an embodiment herein; -
FIG. 8 is a block diagram illustrating aspects of the detector of the apparatus ofFIG. 5 , according to an embodiment herein; -
FIG. 9 is a block diagram illustrating the apparatus ofFIG. 5 with a light source, according to an embodiment herein; -
FIG. 10 is a block diagram illustrating the apparatus ofFIG. 5 with a photodiode, according to an embodiment herein; -
FIG. 11 is a block diagram illustrating aspects of the microchannel reactor of the apparatus ofFIG. 5 , according to an embodiment herein; -
FIG. 12A is a flow diagram illustrating a method of performing a chemical process, according to an embodiment herein; -
FIG. 12B is a flow diagram illustrating a method of introducing an enzyme in the chemical process ofFIG. 12A , according to an embodiment herein; -
FIG. 12C is a flow diagram illustrating a method of immobilizing an enzyme in the chemical process ofFIG. 12B , according to an embodiment herein; -
FIG. 12D is a flow diagram illustrating a method of oxidizing the hydrogen peroxide in the chemical process ofFIG. 12A , according to an embodiment herein; -
FIG. 12E is a flow diagram illustrating a method of exciting the fluorophore in the chemical process ofFIG. 12A , according to an embodiment herein; -
FIG. 12F is a flow diagram illustrating a method of correlating a fluorescence in the chemical process ofFIG. 12A , according to an embodiment herein; -
FIG. 13 is a schematic representation of the chemical process of the method ofFIG. 12A , according to an embodiment herein; -
FIG. 14A is a schematic diagram illustrating a microfluidic device, according to an embodiment herein; -
FIG. 14B is a schematic diagram illustrating a chemical scheme of the enzyme immobilization structure, according to an embodiment herein; -
FIG. 14C is a graphical representation that correlates the protein concentration as a function of flow rate, according to an embodiment herein; -
FIG. 14D is a graphical representation that correlates the fluorescence intensity as a function of flow rate, according to an embodiment herein; -
FIG. 15A is a graphical representation that illustrates the relative fluorophore intensity for various solvents, according to an embodiment herein; -
FIG. 15B is a schematic diagram illustrating a microchannel reactor, according to an embodiment herein; -
FIG. 16A is a schematic diagram illustrating a detector system, according to an embodiment herein; -
FIG. 16B is a graphical representation that correlates the current (corresponding to the fluorescence) as a function of time, according to an embodiment herein; -
FIG. 17 is another graphical representation that correlates the current (corresponding to the fluorescence) as a function of time, according to an embodiment herein; -
FIG. 18 is a schematic diagram illustrating a gas-phase analyte to liquid-phase transfer system, according to an embodiment herein; -
FIG. 19 is a schematic diagram illustrating a vapor generation and sample delivery system for characterizing a gas sample collector using a diffusion vial and sample loop, according to an embodiment herein; -
FIG. 20 is a graphical representation that correlates the integrated area NPD signal from PC-released TBP as a function of collection time, according to an embodiment herein; -
FIG. 21 is a schematic diagram illustrating a gas-to-liquid transfer system, according to an embodiment herein; -
FIG. 22 is a graphical representation that correlates the concentration of TBP in hexane as a function of peak area, according to an embodiment herein; and -
FIG. 23 is a schematic diagram illustrating a system for continuous operation of an air-to-liquid sampler, according to an embodiment herein. - Embodiments of the disclosed invention, its various features and the advantageous details thereof, are explained more fully with reference to the non-limiting embodiments that are illustrated in the accompanying drawings and detailed in the following description. Descriptions of well-known components and processing techniques are omitted to not unnecessarily obscure what is being disclosed. Examples may be provided and when so provided are intended merely to facilitate an understanding of the ways in which the invention may be practiced and to further enable those of skill in the art to practice its various embodiments. Accordingly, examples should not be construed as limiting the scope of what is disclosed and otherwise claimed.
- The embodiments herein provide a gas-to-liquid transfer system to detect the presence of contaminants such as organo-phosphate compounds, among others. A collector collects the air contaminants for transfer to a dual reaction liquid chamber liquid that adds a solvent, such as hexane, to the collected organo-phosphates. A detector is provided to detect the presence of phosphate compounds, for example, by introducing an enzyme such as acetylcholine esterase, cyclooxygenase, or horseradish peroxidase. The embodiments herein utilize fluorescence emissions or other detectors (i.e., electrochemical) to determine the presence of the contaminants.
- Referring now to the drawings, and more particularly to
FIGS. 1 through 23 , where similar reference characters denote corresponding features consistently throughout, there are shown exemplary embodiments. In the drawings, the size and relative sizes of components, layers, and regions may be exaggerated for clarity. -
FIG. 1 illustrates asystem 10 comprising apump 15 to delivervapor 20 comprisingairborne contaminants 25 comprisingorganic compounds 35 comprising atarget analyte 30. Thesystem 10 may be a portable system that is sized to be placed and removed from aircraft or other environmental location where air detection is required. In some examples, thepump 15 may comprise any of an electrical pump, mechanical pump, pneumatic pump, and electro-mechanical pump, or combinations thereof. Theairborne contaminants 25 may comprise a plurality of different types of contaminants. In an example, theorganic compounds 35 may comprise any of organo-phosphate compounds, opioids, cannabinoids, and other classes of organic compounds. Thetarget analyte 30 may be selected based on a predetermined classification of target analytes that are desired to be detected and analyzed. Accordingly, thetarget analyte 30 comprises a chemical signature that thesystem 10 is configured to detect and analyze based on predetermined and/or pre-programmed chemical signature properties that are to be compared against to determine if there is a match, and the level of contamination or concentration of thetarget analyte 30 in thevapor 20. - The
system 10 further comprises acollector 40 to transfer theairborne contaminants 25 by autonomous liquid extraction into a mobile organic liquid phase 45. In an example, thecollector 40 may comprise a gas-to-liquid collector that utilizes collection gels, beads, or other mechanisms to collect theairborne contaminants 25 for transfer by liquid extraction. The mobile organic liquid phase 45 may flow at any suitable rate necessary to carry the liquid phase of theairborne contaminants 25 and correspondingorganic compounds 35. In an example, the mobile organic liquid phase 45 may comprise a non-polar solvent 110. For example, the non-polar solvent 110 may comprise hexane or any other suitable non-polar material. - The
system 10 comprises amicro-fluidic chamber 50 comprising immobilizedbiorecognition elements 52 that bind to analytes 46 delivered from the mobile organic liquid phase 45. For example, thebiorecognition elements 52 may be natural or synthetic. In some examples, thebiorecognition elements 52 may include antibody enzymes, nucleic acid aptamers, or molecularly imprinted polymers. Unbound biorecognition elements 52 (i.e., free of the target analyte 30) compared tobiorecognition elements 52 bound withtarget analytes 30 enable detection. According to the embodiments herein, reagents (not shown) are added in an aqueous phase (e.g., oil in water droplet) to trigger reactions needed for detection of thetarget analyte 30. For example, the reagents may include Amplex® red reagent, among others. Themicro-fluidic chamber 50 may contain a micro-preconcentrator (μ-PC) device (not shown inFIG. 1 ) to control the concentration levels of theorganic compounds 35 to be utilized for testing and analysis in thesystem 10. For example, themicro-fluidic chamber 50 and the μ-PC device may be used to increase the concentration of the organic compounds 35 (and thus, the target analytes 30) from a lower concentration to a higher concentration. - The
system 10 may comprise amechanism 55 to introduce the mobile organic liquid phase 45 to abuffer 60 containing a plurality ofsubstrates 65 causing a series of biochemical reactions that create a change corresponding to a concentration of thetarget analyte 30. In an example, the mobile organic liquid phase 45 may be introduced by drop-wise addition, and thus themechanism 55 may be any suitable device, such as a mechanical dropper, that transfers the mobile organic liquid phase 45 to thebuffer 60. Thebuffer 60 may be any suitable type of buffering solution to control some of the chemical properties associated with the mobile organic liquid phase 45, such as the acidity, etc. For example, thebuffer 60 may comprise any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase reacting with the acetylcholine to convert the acetylcholine to acetate and choline. The plurality ofsubstrates 65 may comprise any suitable type of chemical material or molecules upon which the enzymes in the mobile organic liquid phase 45 act including bonding. Thesystem 10 further comprises adetector 70 to perform real-time analysis 75 that correlates to a concentration of theorganic compounds 35 to determine a presence of thetarget analyte 30. In an example, thedetector 70 may comprise a photodetector configured to detect of fluorescence emission. Moreover, thedetector 70 may comprise any of an electronic, electrochemical, plasmonic, surface plasmon resonance, absorption, emission, electron transfer, and charge transfer device, or combinations thereof, or any other suitable detection system. Thedetector 70 may comprise a processor or may be communicatively linked to a processor, computer, or server device(s) to perform the real-time analysis 75 of theorganic compounds 35 in order to determine the presence of thetarget analyte 30. - In an alternative embodiment, instead of enzymes generating a read-out, the analytes of interest (e.g., target analyte 30) can interact with the
biorecognition elements 52, freeing them from the surface of a microreactor. Thesebiorecognition elements 52 can then be detected downstream using thedetector 70 with or without capture. -
FIG. 2A , with reference toFIG. 1 , illustrates that thecollector 40 may comprise atube 80 comprisingsilica gel 85 coated with axerogel 90 to collect theorganic compounds 35. Thetube 80 may comprise any suitable size or material such as glass or durable plastic, for example. In an example, thesilica gel 85 coated with thexerogel 90 may comprise solid pellets that are positioned in thetube 80. In another example, thesilica gel 85 may comprise viscous gel or material with thexerogel 90 coated thereon, and which are positioned in thetube 80. Accordingly, the embodiments herein are not restricted to any particular configuration of thesilica gel 85 and/orxerogel 90. TheFIG. 2B , with reference toFIGS. 1 and 2A , illustrates that thecollector 40 may comprise aMEMS device 95 to collect theorganic compounds 35. A non-limiting example of a MEMS device/system that could be used for theMEMS device 95 herein is described in Bae, B., et al., “A Fully-Integrated MEMS Preconcentrator for Rapid Gas Sampling,” U.S. Air Force Report AFRL-PR-WP-TP-2007-224 for submission of a Conference paper submitted to the Proceedings of the Transducers 2007 Conference, Mar. 19, 2007, pp. 1-4, the complete disclosure of which, in its entirety, is herein incorporated by reference. -
FIG. 3 , with reference toFIGS. 1 through 2B , illustrates that thesystem 10 may comprise areservoir 100 to hold the mobile organic liquid phase 45. Thereservoir 100 may be any suitable type of liquid chromatographic instrument that may be configured to retain the mobile organic liquid phase 45. In an example, the reservoir may be configured to contain pressurized solvent and may comprise vacuum connections for drawing the mobile organic liquid phase 45 therefrom and/or thereto. - The
system 10 may comprise avalve 105 to control delivery of the mobile organic liquid phase 45 into thecollector 40. Thevalve 105 may comprise any suitable type of electrical, mechanical, pneumatic, or electro-mechanical valve, or combinations thereof. Moreover, thevalve 105 may be automatically controlled by a local or remote processor or controller (not shown) or controlled by user intervention, as necessary.FIG. 4 , with reference toFIGS. 1 through 3 , illustrates that thesystem 10 may comprise analarm 115 that is triggered upon detection of the presence of thetarget analyte 30 above a predetermined level. Thealarm 115 may comprise any of an audio alarm, visual alarm, or combinations thereof. Thealarm 115 may be communicatively coupled to thedetector 70 and/or a processor or computer that transmits a signal to thealarm 115 upon thedetector 70 detecting the presence of thetarget analyte 30 above a pre-programmed predetermined level. Since the detection and analysis of the presence of thetarget analyte 30 occurs in real-time, thealarm 115 is also triggered in real-time to alert users (i.e., pilots or other aircraft personnel, for example) to exit the aircraft or otherwise take precautionary measures to protect themselves from a potentially toxic environment due to the presence of thetarget analyte 30. Moreover, thealarm 115 may comprise variable outputs based on the level of the presence of thetarget analyte 30. For example, a yellow light may be output to indicate the presence of thetarget analyte 30 at levels that are not considered immediate health threats. Alternatively, a red light may be output to indicate a significant health threat to personnel in the vicinity of thesystem 10 andvapor 20. Similarly, the variable outputs may be audio-based with different pitches, tones, or frequencies depending on the level of the threat that is detected. In another example, the audio output from thealarm 115 may be a computer-generated voice providing instructions for personnel as well as outputting the type oftarget analyte 30 that has been detected as well as the level (i.e., amount) of detection. -
FIG. 5 , with reference toFIGS. 1 through 4 , illustrates another embodiment that provides anapparatus 150 comprising acollector 40 to collect a plurality of organic classes ofcompounds 155 from anair sample 160. Theapparatus 150 may be miniaturized to be portable and easily transferred from various settings such as aircraft, for example. The plurality of organic classes ofcompounds 155 may comprise any of organo-phosphate compounds, opioids, cannabinoids, and other classes of organic compounds, according to some examples. Theair sample 160 may be the ambient air in an aircraft cockpit, for example. However, theair sample 160 and corresponding environmental location for using theapparatus 150 may be any suitable location where the detection and analysis of theair sample 160 is required. - The
apparatus 150 comprises amicro-fluidic chamber 50 to combine the collected plurality of organic classes ofcompounds 155 with a biochemically and chemically reactive mobile phase analytic solution 170 (e.g., which may be thebuffer 60 containing the plurality ofsubstrates 65, for example). According to an example, single or multiple pairs of immiscible liquids may extract and transfer contaminants to the biochemically and chemically reactive mobile phaseanalytic solution 170. Theapparatus 150 further comprises adetector 70 to detect a presence ofphosphate compounds 175 in the mobile phaseanalytic solution 170. As such, the mobile phaseanalytic solution 170 may be any suitable type of buffering solution to control chemical properties, and may contain any suitable type of chemical material or molecules upon which enzymes act, including bonding. In an example, the mobile phaseanalytic solution 170 may comprise the mobile organic liquid phase 45, described above, of the collected plurality of organic classes ofcompounds 155. -
FIG. 6A , with reference toFIGS. 1 through 5 , illustrates that theapparatus 150 may comprise acolumn 180 containing axerogel 90 coatedsilica gel 85 to collect the plurality of organic classes ofcompounds 155. Thecolumn 180 may comprise any suitable size or material such as glass or durable plastic, for example. In an example, thesilica gel 85 is coated with thexerogel 90 and may comprise solid pellets that are positioned in thecolumn 180. In another example, thesilica gel 85 may comprise viscous gel or material with thexerogel 90 coated thereon, and which are positioned in thecolumn 180. According to an example, thecolumn 180 may be configured to withstand pressured liquids including the mobile phaseanalytic solution 170, the mobile organic liquid phase 45, or other liquids, solvents, or solutions. Theapparatus 150 may comprise a heater 185 to heat thecolumn 180. The heater 185 may comprise any suitable type of heater 185 that can be automatically and/or manually controlled to heat thecolumn 180 to desired temperatures. In an example, the heater 185 may be used to heat to thecolumn 180 to help facilitate a separation process of the mobile phaseanalytic solution 170. -
FIG. 6B , with reference toFIGS. 1 through 6A , illustrates that theapparatus 150 may comprise aMEMS device 95 to collect the plurality of organic classes ofcompounds 155.FIG. 7 , with reference toFIGS. 1 through 6B , illustrates that theapparatus 150 may comprise amicrochannel reactor 190 comprising immobilizedacetylcholine esterase 195 or other alternative selective enzyme or aptamer that is inhibited by the phosphate compounds 175 that is introduced to the collected plurality of organic classes ofcompounds 155 and the mobile phaseanalytic solution 170. According to an example, themicrochannel reactor 190 may comprise a continuous plug flow reactor, although other types of reactors may be utilized in accordance with the embodiments herein. Themicrochannel reactor 190 may comprise a series of serpentine channels in which the chemical reactions of the mobile phaseanalytic solution 170 occur. Moreover, themicrochannel reactor 190 may be configured to have suitable heat exchange thermal properties to withstand exothermic reactions of the mobile phaseanalytic solution 170. -
FIG. 8 , with reference toFIGS. 1 through 7 , illustrates that thedetector 70 may comprise abuffer 60. As described above, and in some examples, thebuffer 60 may comprise any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase reacting with the acetylcholine to convert the acetylcholine to acetate and choline. Thebuffer 60 is to detect acetylcholine esterase activity and trigger a fluorescent-producing reaction and create afluorophore 200 upon detecting a presence ofacetylcholine esterase 195 that is inhibited by the phosphate compounds 175 in the mobile phaseanalytic solution 170 resulting in a quenching of the enzyme comprising any of the acetylcholine esterase, cyclooxygenase, and horseradish peroxidase. Thefluorophore 200 may be any suitable type of fluorescent chemical compound capable of re-emitting light upon excitation caused by the reaction of thebuffer 60. -
FIG. 9 , with reference toFIGS. 1 through 8 , illustrates thatapparatus 150 may comprise alight source 205 to excite thefluorophore 200. In an example, thelight source 205 may comprise a light-emitting diode (LED) or any other suitable light generating and emitting device.FIG. 10 , with reference toFIGS. 1 through 9 , illustrates thatapparatus 150 may comprise aphotodiode 210 to measure thefluorophore 200. Thephotodiode 210 may be configured to measure the light emitted by thefluorophore 200 and convert the light into an electrical current. According to an example, the concentration of the phosphate compounds 175 is inversely proportional to the excitation of thefluorophore 200, which indicates the presence of the toxins (based on a predetermined chemical signature as described above) from the plurality of organic classes ofcompounds 155 in theair sample 160.FIG. 11 , with reference toFIGS. 1 through 10 , illustrates thatmicrochannel reactor 190 may comprise aliquid chamber 215 containing adrop-wise addition channel 220, according to an example. Theliquid chamber 215 anddrop-wise addition channel 220 may be any suitable devices and instruments capable of retaining and transferring the aforementioned solvents and solutions used in theapparatus 150. -
FIG. 12A , with reference toFIGS. 1 through 11 , is a flow diagram illustrating amethod 300 according to an embodiment herein.FIG. 13 illustrates a schematic representation of the chemical process described by themethod 300. According to an example, themethod 300 comprises converting (305) acetylcholine to acetate and choline; oxidizing (310) the choline to derive betaine aldehyde and hydrogen peroxide; oxidizing (315) the hydrogen peroxide to generate a hydrogen ion and electron; and generating (320) afluorophore 200 from the hydrogen ion and electron.FIG. 12B , with reference toFIGS. 1 through 12A , is a flow diagram illustrating that themethod 300 may comprise introducing (325) an enzyme comprising any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase to the acetylcholine to convert the acetylcholine to acetate and choline.FIG. 12C , with reference toFIGS. 1 through 12B , is a flow diagram illustrating that themethod 300 may comprise immobilizing (330) the enzyme.FIG. 12D , with reference toFIGS. 1 through 12C , is a flow diagram illustrating that themethod 300 may comprise oxidizing (335) the hydrogen peroxide by a peroxidase.FIG. 12E , with reference toFIGS. 1 through 12D , is a flow diagram illustrating that themethod 300 may comprise exciting (340) thefluorophore 200 to fluorescence.FIG. 12F , with reference toFIGS. 1 through 12E , is a flow diagram illustrating that themethod 300 may comprise correlating (345) the fluorescence to an inverse correlation of a concentration of organo-phosphates. - AChE is an important enzyme that breaks down acetylcholine, a key substance as a neurotransmitter. Organo-phosphates are toxic because they inhibit AChE activity by binding on the active site of AChE covalently. The embodiments herein provide an inhibition mechanism to detect the organo-phosphate in the air, as depicted in
FIG. 13 , with reference toFIGS. 1 through 12F . There are three reactions which are concerned with three enzymes of AChE, COX, and HRP.Reaction 1 is a degradation reaction that converts acetylcholine to acetate and choline with AChE.Reaction 2 is an oxidation reaction of choline in which betaine aldehyde and hydrogen peroxide are derived, and the hydrogen peroxide is oxidized by peroxidase to generate hydrogen ion and electron. The hydrogen and electron activate the fluorescence substrate. The fluorescence is excited at 550 nm and 600 nm light is emitted. - The embodiments herein were experimentally tested according to the following series of experiments. The specific devices, orientations, configurations, geometries, sizes, temperatures, timings, ratios, speeds, techniques, colors, and/or types and amounts of materials, etc. described in the experiments below are merely exemplary, and the embodiments herein are not restricted to any particular structure, property, technique, or material described below. Accordingly, the experiments are merely being presented to demonstrate the feasibility of the embodiments herein and are not meant to restrict how the invention may be practiced.
- The
microchannel reactor 190 may comprise a serpentinemicrofluidic channel 401 as depicted inFIG. 14A , and which may be fabricated by soft-lithography processing. For example, photo-lithography is used to make the mold, and white polydimethylsiloxane (PDMS, 1:10 ratio of cross linker and monomer) 403 is cured on the mold at 70° C. after spin coating at 250 RPM. Themicrofluidic channel 401 formed by soft-lithography is then covered with a transparent slab ofPDMS 403. The surface of themicrofluidic channel 401 is exposed to UV-plasma to generate hydroxyl groups on the surface, to allow functionalization with amine groups via (3-aminopropyl) triethoxylane (3-APTES). Acetone and 3-APTES are mixed at a 7:3 ratios, and injected into themicrofluidic channel 401 at a 100 μL/min flow rate at approximately 60° C. for approximately 4 hours. After functionalization, a cross-linker is developed using glutaraldehyde at a 6:4 ratio of PBS (phosphate buffer saline) and glutaraldehyde mixture (glutaraldehyde 10% in PBS) and injected at ˜50 μL/min flow rate for approximately 4 hours. Finally, enzymes of acetylcholinesterase (AChE, ˜12.5 choline oxidase (COX, ˜12.5 μL/mL), and horseradish peroxidase (HRP, ˜5 μL/mL) are immobilized on the surface of themicrofluidic channel 401.FIG. 14B shows the chemical scheme of theenzyme immobilization structure 407 on thePDMS 403. Theprepared microchannel reactor 190 is filled with PBS and stored at approximately 4° C. The chain reaction using themicrochannel reactor 190 is performed with reactant mixtures of acetylcholine (˜100 μM) and fluorescence substance (˜5 μL) as the mixture is injected into themicrochannel reactor 190 at ˜200 μL/min flow rate at approximately 30° C. Fluorescence from the reaction is excited at ˜550 nm wavelength (green light), and emitted at ˜600 nm (orange light). - The
microchannel reactor 190 is prepared as all enzymes are immobilized on the surface of thechannel 401. The cross-linker quantity and enzyme binding amount are controlled by changing functionalization time and flow rate.FIG. 14C depicts the flow rate results. High enzyme immobilization level leads to high enzyme activity in themicrochannel reactor 190. Excessively high activity, however, leads to saturation in the fluorescence intensity, and such high activity can dilute the effect of organo-phosphate inhibition. Such competitive inhibition is usually solved with excessive enzyme amount. Thus, an appropriate enzyme amount should be immobilized to for high sensitivity of organo-phosphate inhibition. As with the functionalization time, the quantity of cross-linker can be varied. For high sensitivity of inhibition response, the functionalization time is determined at over 2 hours. The flow rate for enzyme immobilization is ˜30 μL/min as denoted by the dashed box inFIG. 14C . If a high level of protein is immobilized, the sensitivity decreases. A flow rate of 30 μL/min yields an appropriate reaction rate. Fluorescence is very sensitive, and it shows reasonable intensity with μmon concentration level of acetylcholine. When the flow rate is ˜30 μL/min, the relative fluorescence intensity is ˜75% of saturated intensity as indicated in the results ofFIG. 14D . - The
collector 40 may be an air-to-liquid (gas-to-liquid) tributyl phosphate (TBP)collector 40. The TBP collection may include a gas-to-liquid extractor that is utilized in a laboratory hood. A beaker containing ˜10 mL TBP is placed adjacent to a probe on theTBP collector 40. Thecollector 40 sniffs TBP, and the membrane is rinsed with hexane. The TBP on the membrane dissolves in hexane, and finally the TBP can be collected in a 1 mL syringe for injection into the reaction-detection system. - The
microchannel reactor 190 is experimentally tested with non-polar organic solvents. With respect to the gas-to-liquid TBP collector 40, the elute of sensor system includes solvents. The reactant with fluorescence substrate is, however, a water-based solution. Thus, droplet generating microfluidics is introduced. As indicated inFIG. 15A , various solvents are experimentally considered in terms of conservation of enzyme in themicrochannel reactor 190 activity as denoted by the relative fluorophore intensity. Hexane is experimentally determined to be an appropriate solvent for both the gas-to-liquid TPB collector 40 and themicrochannel reactor 190. Thedrop-wise addition channel 220 may also be embedded in themicrochannel reactor 190.FIG. 15B shows an experimental configuration of themicrochannel reactor 190. Continuous flow reaction was conducted using themicrochannel reactor 190 prepared with the optimum conditions of an enzyme immobilization and organic solvent/water hybrid flow system. As a result, the fluorescence is observed from a cuvette 209 (denoted inFIG. 16A ) in which the fluorescence substrate is connected with the product of the enzyme reaction to generate fluorescence luminescence. The fluorescence is observed at ˜600 nm wavelength, excited at 550 nm wavelength. In the test of the sensing system, an inhibition substrate (e.g., TBP) is used at each concentration. Reactant flow rate also affects the inhibition, and the flow rate is determined to be ˜50 μL/min. As the inhibitor solubilized flow passes into themicrochannel reactor 190, the fluorescent intensity is observed to decrease. The competitive inhibition of TBP is direct, and the signal of fluorescence changes instantly. - The schematic configuration of the
detector 70 is shown inFIG. 16A . Various geometries may be considered for effective detection of fluorescence emission in themicro-channel reactor 190 and structures for direct lighting-detecting are determined. For fast detection of signal, thedetector 70 size should be miniaturized to allow integration with themicro-fluidic chamber 50. For example, millimeter-sized components are used. Anexcitation light source 205 to generate light 206 may comprise anLED 207 and apolarizing filter 208. Acuvette 209 is positioned in the pathway of the light 206. Green filters may be used to reject stray light and excitation light. As emission wavelengths from themicrochannel reactor 190, 570 nm, 590 nm, and 610 nm polarizing filters which reject each wavelength are tested, and thephotodetector 70 is placed behind polarizing thefilters 208 and are selected with suitable properties. - With respect to the data acquisition process, the current from the
photodetector 70 is measured using a digital multi-meter (DMM) 204. As the system is operated, thedetector 70 determines the fluorescence intensity associated with continuous reactant flow. The continuous changes in current are recorded and stored in acomputer 203. The noise from the recorded data may be removed by adjusting a low pass digital filter as part of the data processing. - The fluorescence intensity is detected after emission of the light. The
detector 70 mechanism is based on a fluorescence microscope. Green LEDs (550 nm) are selected and tested as excitation light sources with small sizes and strong output intensity. Thephotodetectors 70 should be sensitive at near red color light. ThePolarizing filter 208 rejects all wavelengths below the emission wavelength. 570 nm and 590 nm filters are experimentally tested, and a high quality of wavelength rejection is realized with a 610 nmpolarizing filter 208. Emission of the fluorescence substrate is known to be 600 nm, but a small size of the detected signal creates challenges in eliminating effects of light scattering penetration ofexcitation light 206 through thepolarizing filter 208. Therefore, over 600 nm filters can be utilized. As the results of using a 610nm filter 208, a small portion of fluorescence emission is rejected but the fluorescence information is more clea, and robust. Based on these efforts, all components were assembled with poly(methyl methacrylate) (PMMA). A two-dimensional laser cut PMMA pieces are bonded with epoxy, and ablack PDMS 202 is used to cover the surroundingdetector 70 to prevent light penetration from outside. Also, an aluminum channel is tested. The design of both the PMMA and aluminum detection channels are determined after optimization of various geometries of the positions of theexcitation light source 205 andphotodetector 70. When thedetector 70 is prepared and integrated with themicrochannel reactor 190, fluorescence intensity can be monitored and captured with acomputer 203. The fluorescence information is collected by thedetector 70, and the photodetector portion of thedetector 70 generates current as the fluorescence intensity in the microfluidics.FIG. 16B summarizes the results.Time 0 is the starting point of inhibition and at ˜200 pM TBP, the fluorescence changes as shown inFIG. 16B . The current scale is around nA before optimization.FIG. 16B shows results at the μA scale, which is significantly improved in terms of sensitivity and stability for actual use. - The developed sensing-detecting system should be integrated with the
TBP collector 40. The experimental organo-phosphate detection system was designed and tested at the bread board level. The normal state of the system shows normal reaction conditions in which the chain reaction is performed. The chain reaction leads to the production of hydrogen which activates the fluorescence substrate (FIG. 13 ). The system shows fluorescence intensity corresponding to acetylcholine concentration, and the fluorescence intensity is affected by acetylcholine concentration and AChE activity. The system has continuous flow while it is operated. During flow operation, there is a constant amount of acetylcholine (10 mM) and fluorescence substrate (50 μl/mL). Thus, AChE activity affects the fluorescence intensity and if there is a strong inhibitor in the elute, AChE activity will be decreased. The normal state of the system, therefore, should show constant intensity of fluorescence. The alternating flow of hexane and reactant by the droplet generator for merging two flows is read out by thefluorescence detector 70 inFIG. 16A . Experimentally, a strong pink color indicated that the enzyme chain reactions are in the stationary phase. TheTPB collector 40 is operated and TBP in the air could be collected and resolved into hexane. The system is a batch type and the TBP could be recovered by hexane flushing by two syringes. When the syringe with collected TBP is injected into the system, the reaction is inhibited. -
FIG. 17 shows the results of all experimental system operations. Thefluorescence detector 70 generates current as there is over 610 nm light in the detector channel, and the signal data is the current value. The reaction system was stationary phase by ˜400 sec. The constant fluorescence intensity reflects normal enzymatic activity. After 400 sec, as the TBP syringe is injected, the signal decreases which means that inhibition of AChE occurs by the TBP collected from air. The dashed adjoint line inFIG. 17 is filtered data which results from low pass filter adjustment. The decreased rate can be calculated to derive TBP concentration. With different amounts of organo-phosphates, the level of decreasing rate will be different. A high amount of organo-phosphate would lead to a more rapid decrease in fluorescence intensity. The calibration of decrease rate should be conducted for practical use. It is noted that enzyme activity can deactivate naturally as it is used. The deactivation without the presence of organo-phosphates should be addressed to yield stable operation in practical conditions. The effect is expected not to be significant, and it would be a slight change of the intensity. Therefore, the system should have a reference reactor which only has the flow of the reactant and fluorescence substrate. The reference reactor would improve the sensitivity and reliability of the system. Also, an automated data processing system could be developed for practical use in situ. - An exemplary
TBP detection system 500 that was experimentally tested is illustrated inFIG. 18 . Generally, thesystem 500 comprises anAChE reservoir 502 operatively connected to an air-to-liquid micro-preconcentrator (μ-PC) 506. Anair sample inlet 508 inputs into the μ-PC 506 also. An airsample vacuum pump 510 is operatively connected to the μ-PC 506. Amicrochannel reactor substrate 520 is operatively connected to the μ-PC 506. Themicrochannel reactor 520 comprises atransparent substrate cover 514, aLED light source 516, and a charge-coupled device (CCD) 518 as a photodiode for sensing emitted light. Anenzyme reservoir 504 andwaste reservoir 522 are operatively connected to themicrochannel reactor substrate 520. Avacuum pump 512 for AChE transfer is operatively connected to thewaste reservoir 522. A low-concentration mix of TBP in air passes over the μ-PC 506 where TBP is collected. The μ-PC 506 rapidly heats to develop a concentrated pulse of TBP vapor in a small chamber that encloses the μ-PC 506. A portion of the concentrated pulse accumulates in solvent on the opposite side of a membrane that forms one wall of the chamber. The elevated concentration and temperature enhance the transfer of TBP into solvent. Solvent with the collected TBP is transferred to the detector, where it is incubated with an immobilized acetylcholine esterase within amicrochannel reactor 520. Aqueous solution for detection of acetylcholine esterase activity then passes over the immobilized enzyme, triggering a reaction producing a fluorescent substrate only if acetylcholine esterase is present and uninhibited by organophosphates/nerve agents. The LEDlight source 516 at 550 nm excites the fluorophore, and the emission is measured at 600 nm on a photodiode (CCD) 518. The percent reduction of fluorescence correlates with the concentration of TBP in the sample. - Hexane is brought into direct contact with the xerogel in the μ-
PC 506 material. A pair of valves may be used to direct air and liquid flows during the sample collection cycle and the flush cycle where TBP is transferred to hexane. Between collection cycles, the μ-PC 506 material is heated and dried with air. - TBP is placed in a diffusion vial and set in a heated chamber with continuous 100 mL/min flow of zero air. The flux rate from the vial is determined gravimetrically by weekly weight measurements. With a D size diffusion vial with a 1-inch stem at ˜80° C., the flux rate is determined to be 317 ng/min. This correlates with the estimated 390-ng/min flux rate for this vial. Since the sweep gas is 100 mL/min, the maximum concentration that can be delivered is approximately 400 ppb. The
system 500 has a 500-μL sample loop so 2-ng of sample can be delivered to the test chamber shown inFIG. 19 . Sample loops of 100 μL and 10 μL can also be used, and the sample stream could also be diluted to deliver lower concentrations of TBP samples. - The
vapor system 500 was used to test some of the air-to-liquid sample collector concepts, but testing was also conducted with headspace samples of TBP in an open container. To estimate the concentration in headspace air samples, the upper limit can be determined by comparing the vapor pressure of TBP at ambient temperatures to the ambient pressure. At 25° C. the vapor pressure of TBP is on the order of 0.00113-mmHg. During testing, the barometric pressure is nominally 640-mmHg, so the concentration in the headspace is approximately 1.8-ppm. However, the concentration could be at least an order of magnitude lower as indicated in Skene, W., et al. “Vapor Pressure of Tri-n-Butyl Phosphonate,” J. Chem. Eng., Data, 1995, 40, pp. 394-397, the complete disclosure of which, in its entirety, is herein incorporated by reference. Sampling headspace requires the dense vapor to travel up a container from the liquid surface and mix with the air. As a dense vapor, TBP would require a long equilibration time. Therefore, in working with headspace samples of TBP in air, it is estimated that the concentration is between 100 ppb and 1 ppm by volume. - The roll of the μ-
PC 506 in thesystem 500 is to capture the TBP in the air and concentrate it for delivery to the liquid. A series of tests were conducted to quantify the TBP capture and release properties for the μ-PC 506. The high-surface area μ-PC 506 is first exposed to the TPB stream and then the valve is switched to connect the μ-PC 506 to a nitrogen phosphorous detector (NPD). Voltage is applied to a heater on the μ-PC 506 to produce a concentrated plume on analyte on the NPD.FIG. 20 shows that the integrated area NPD signal trace is proportional to the mass of TBP that flows to the detector. The mass collected is proportional to the collection time, at least up to 5 minutes. Further testing shows that the linearity falters at long collection times. At 15 minutes, the measured total peak area is about 75% of the linear predicted area. - The ability of the μ-
PC 506 to retain a sample of TBP is also tested. Even with warm nitrogen blowing over the surface of the μ-PC 506 for 4 extra minutes, there is no apparent loss in captured TBP. Certainly, longer intervals and higher flushing volumes will remove the TBP, but the xerogel coating has a high affinity for TBP to prevent quick loss in the captured TBP. - To estimate concentration capabilities of the μ-
PC 506, the system is calibrated with a 500-μL sampling loop. This loop replaces the μ-PC 506 to introduce a known quantity of analyte to the NPD. The TBP sample is generated with a D-sized diffusion vial in an oven at 80° C. The flux rate of TBP is estimated to be 393 ng/min. The flow rate of the zero-air sweep gas through the diffusion vial chamber is measured with a bubble meter to be 55.1 mL/min. Based on these measurements, the concentration of TBP in the stream is 7.16 ng/mL, so a 500-μL sample loop would contain 3.58 ng of TBP. - Experimentally, it was determined that hexane could be flushed directly over the μ-
PC 506 to remove concentrated TBP. An experimental apparatus shown inFIG. 21 was developed where the preconcentrator is a bed ofmicrobeads 550 that are coated with xerogel. Themicrobeads 550 are packed in a tube that is wrapped with a heater for drying the packed bed after the hexane extraction.Valves - During the TBP collection cycle, the
valves pump 555 pulls TBP-contaminated air through themicrobeads 550. After collecting for a set amount of time, typically 10's of minutes, thepump 555 is switched off and thevalves microbeads 550 using a 1-mL syringe 554. The hexane is then withdrawn through the same port and transferred to a detector system. A second syringe of clean hexane is flushed in and out of the collection tube to remove TBP remaining on themicrobeads 550. Thevalves pump 555 and heaters are also switched on. The PC tube is heated to 60° C. to vaporize any remaining hexane. At this temperature, all hexane is removed in less than five minutes. - The micro-bead packed PC system is tested to determine the concentration of TBP in the solvent. The original calibration is performed with acetonitrile, but the calibration is repeated with the hexane solvent and NPD. Five concentrations are run from 2 μg TBP/Liter hexane to 1000 μg/L, and the correlation between the area of the TBP peak and the concentration is shown in
FIG. 22 . - Tests were performed where TBP in air was drawn into the collector from the headspace above the surface of liquid TBP. After a collection of 25 minutes, 1 mL of hexane is injected into the μ-
PC 506 and withdrawn from the same port. When 1-4, of this sample is injected into the calibrated flame ionization detector (FID), the peak area corresponds to 4.8 ng of TBP in the sample. A second flush 1-mL of hexane in the μ-PC 506 shows that the concentration goes to 8.4 ng of TBP, but a third flush of hexane shows that the μ-PC 506 is clean. Similar tests are performed at 5 and 10-minute collect times. -
FIG. 23 illustrates one exemplary approach for automating the collector and detector in the system. In this system shown inFIG. 23 ,pump 1 andvalve 1 are energized to pull an air sample into the collector. Check valves at the inlet of the μ-PC trap only allows the flow to come from one port of a tee at the inlet. After the collection, pump 2 andvalve 2 energize to flush hexane back through the μ-PC trap. A check valve at the inlet tee directs the flow to the detector system. After a couple of trap volumes of hexane is flushed through the μ-PC,valve 2 de-energizes, and air pushes remaining hexane out of the trap. Additionally, pump 1,valve 1, and the heater can be activated to dry the trap before the next collection cycle. - Accordingly, the experiments demonstrate an organo-phosphates detection system based on an inhibition mechanism for acetylcholinesterase. A
microchannel reactor 190 with chain reaction to yield fluorescence is experimentally demonstrated and a detection sub-system is constructed to readout the fluorescence intensity. The gas-to-liquid TBP collector 40 gathers TBP in the air, and transfers it to the liquid (hexane), which is injected into the enzymaticreaction microchannel reactor 190. Thedetector 70 allows sensing of changes in the reaction rate by measuring the inverse proportionality to organo-phosphate concentration to fluorescence. - The foregoing description of the specific embodiments will so fully reveal the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. Those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the appended claims.
Claims (11)
1. A method comprising:
converting acetylcholine to acetate and choline;
oxidizing the choline to derive betaine aldehyde and hydrogen peroxide;
oxidizing the hydrogen peroxide to generate a hydrogen ion and electron; and
generating a fluorophore from the hydrogen ion and electron.
2. The method of claim 1 , comprising introducing an enzyme comprising any of acetylcholine esterase, cyclooxygenase, and horseradish peroxidase to the acetylcholine to convert the acetylcholine to acetate and choline.
3. The method of claim 1 , comprising immobilizing the enzyme.
4. The method of claim 1 , comprising oxidizing the hydrogen peroxide by a peroxidase.
5. The method of claim 1 , comprising exciting the fluorophore to fluorescence.
6. The method of claim 5 , comprising correlating the fluorescence to an inverse correlation of a concentration of organo-phosphates.
7. A method for detection of an organo-phosphate, the method comprising:
receiving a vapor;
transferring the vapor to an organic liquid phase by autonomous liquid extraction;
exposing the organic liquid phase to an enzyme and a reagent, the enzyme configured to react with the reagent to yield a hydrogen ion and an electron, the enzyme comprising acetylcholine esterase, cyclooxytenase, horseradish peroxidase, or combinations thereof;
transferring the exposed organic liquid phase to a substrate configured to chemically react with the hydrogen ion and the electron to yield a fluorophore; and
detecting fluorescence of the fluorophore when the organo-phosphate is not present in the vapor or detecting a reduced fluorescence when the organo-phosphate is present in the vapor,
wherein the organo-phosphate inhibits the enzyme thereby reducing a yield of the fluorophore and decreases the fluorescence.
8. The method of claim 7 , wherein receiving the vapor includes a gas-to-liquid collector.
9. The method of claim 8 , wherein the gas-to-liquid collector comprises a tube comprising silica gel coated with a xerogel.
10. The method of claim 8 , wherein the gas-to-liquid collector comprises a microelectromechanical systems (MEMS) device.
11. The method of claim 7 , further comprising:
triggering an alarm upon detection of fluorescence.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/151,935 US20230158497A1 (en) | 2018-04-10 | 2023-01-09 | Air to liquid micro-fluidic chamber |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862655478P | 2018-04-10 | 2018-04-10 | |
US16/379,890 US11548001B1 (en) | 2018-04-10 | 2019-04-10 | Air to liquid micro-fluidic chamber |
US18/151,935 US20230158497A1 (en) | 2018-04-10 | 2023-01-09 | Air to liquid micro-fluidic chamber |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/379,890 Division US11548001B1 (en) | 2018-04-10 | 2019-04-10 | Air to liquid micro-fluidic chamber |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230158497A1 true US20230158497A1 (en) | 2023-05-25 |
Family
ID=84810624
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/379,890 Active US11548001B1 (en) | 2018-04-10 | 2019-04-10 | Air to liquid micro-fluidic chamber |
US18/151,935 Pending US20230158497A1 (en) | 2018-04-10 | 2023-01-09 | Air to liquid micro-fluidic chamber |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/379,890 Active US11548001B1 (en) | 2018-04-10 | 2019-04-10 | Air to liquid micro-fluidic chamber |
Country Status (1)
Country | Link |
---|---|
US (2) | US11548001B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5858457A (en) | 1997-09-25 | 1999-01-12 | Sandia Corporation | Process to form mesostructured films |
US7469076B2 (en) * | 2003-09-03 | 2008-12-23 | Receptors Llc | Sensors employing combinatorial artificial receptors |
US20070116607A1 (en) * | 2005-11-23 | 2007-05-24 | Pharmacom Microlelectronics, Inc. | Microsystems that integrate three-dimensional microarray and multi-layer microfluidics for combinatorial detection of bioagent at single molecule level |
EP2102658B1 (en) * | 2007-01-19 | 2019-05-15 | Circassia Ab | Analysis device and method for detecting nitric oxide in a gas phase |
-
2019
- 2019-04-10 US US16/379,890 patent/US11548001B1/en active Active
-
2023
- 2023-01-09 US US18/151,935 patent/US20230158497A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11548001B1 (en) | 2023-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6300638B1 (en) | Modular probe for total internal reflection fluorescence spectroscopy | |
Allouch et al. | Transportable, fast and high sensitive near real-time analyzers: Formaldehyde detection | |
US20110226962A1 (en) | Method and apparatus for detecting fluorescence emitted by particle-bound fluorophores confined by particle traps | |
US7812938B2 (en) | Integrated chemical separation light scattering device | |
Hindson et al. | Development of an automated sample preparation module for environmental monitoring of biowarfare agents | |
Soares et al. | An ultrarapid and regenerable microfluidic immunoassay coupled with integrated photosensors for point-of-use detection of ochratoxin A | |
Long et al. | Adsorption kinetics of pesticide in soil assessed by optofluidics-based biosensing platform | |
WO2014207731A1 (en) | Spr and raman spectral image unit for biochemical assays in the form of a plate | |
WO2009139889A3 (en) | Apparatus and method for optically sensing analyte concentration in an erythrocyte-containing fluid | |
US20230158497A1 (en) | Air to liquid micro-fluidic chamber | |
JP2015178993A (en) | Detection device | |
US6649417B2 (en) | Tissue-based standoff biosensors for detecting chemical warfare agents | |
JP4517079B2 (en) | Slab optical waveguide spectral chemical sensor | |
EP3981737A1 (en) | A nanowire molecular sensor | |
Fernández-Sánchez et al. | Fluorescence optosensors based on different transducers for the determination of polycyclic aromatic hydrocarbons in water | |
JP2007068531A (en) | Detection method for agrochemicals, detection kit for agrochemicals, and detection strip for agrochemicals | |
Eswar et al. | Lock-in amplified fluorescence spectroscopy in a digital microfluidic configuration for antibiotic detection of ciprofloxacin in milk | |
EP3317649B1 (en) | Quantification of topologically arranged luminescent dyes | |
EP2356443B1 (en) | Lead assay | |
JP4830110B2 (en) | Inspection chip with optical amplification element | |
Chang et al. | Automatic microfluidic fluorescence-array measurement system for detecting organic phosphate | |
Power et al. | A Centrifugal Microfluidic Sensing Platform for the Detection of Contaminants in the Marine Environment | |
Lee et al. | Detection of 6-benzylaminopurine plant bioregulator using an opto-fluidic ring resonator (OFRR) biosensor | |
EP3589936B1 (en) | Planar waveguide device with nano-sized filter | |
Zeng et al. | A highly efficient and selective rapid detection method applied to the detection of amide herbicides in fish serum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |